Scott D Collins
Overview
Explore the profile of Scott D Collins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
899
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bukhalid R, Duvall J, Lancaster K, Catcott K, Malli Cetinbas N, Monnell T, et al.
Clin Cancer Res
. 2025 Mar;
PMID: 40029253
Purpose: Targeted tumor delivery may be required to potentiate the clinical benefit of innate immune modulators. The objective of the study was to apply an antibody-drug conjugate approach to STING...
2.
Thomas J, Yurkovetskiy A, Yin M, Bodyak N, Tang S, Protopopova M, et al.
Mol Cancer Ther
. 2024 Feb;
23(4):541-551.
PMID: 38354416
Although microtubule inhibitors (MTI) remain a therapeutically valuable payload option for antibody-drug conjugates (ADC), some cancers do not respond to MTI-based ADCs. Efforts to fill this therapeutic gap have led...
3.
Smith R, England A, Millis J, Hirn C, Collins S, Connell L
Anal Chem
. 2023 Nov;
95(48):17494-17501.
PMID: 37976075
This paper presents the design, microfabrication, and demonstration of a novel microfluidic grinding mill for the lysis of the dinoflagellate, , a neurotoxin-producing genus of algae that is responsible for...
4.
Duvall J, Thomas J, Bukhalid R, Catcott K, Bentley K, Collins S, et al.
J Med Chem
. 2023 Jul;
66(15):10715-10733.
PMID: 37486969
While STING agonists have proven to be effective preclinically as anti-tumor agents, these promising results have yet to be translated in the clinic. A STING agonist antibody-drug conjugate (ADC) could...
5.
Toader D, Fessler S, Collins S, Conlon P, Bollu R, Catcott K, et al.
Mol Cancer Ther
. 2023 Jun;
22(9):999-1012.
PMID: 37294948
Antibody-drug conjugates (ADC) achieve targeted drug delivery to a tumor and have demonstrated clinical success in many tumor types. The activity and safety profile of an ADC depends on its...
6.
Chennampally P, Sayed-Zahid A, Soundararajan P, Sharp J, Cox G, Collins S, et al.
Sci Rep
. 2021 Sep;
11(1):19743.
PMID: 34588612
No abstract available.
7.
Chennampally P, Sayed-Zahid A, Soundararajan P, Sharp J, Cox G, Collins S, et al.
Sci Rep
. 2021 Sep;
11(1):18168.
PMID: 34518579
TAR DNA-binding protein-43 (TDP-43) is known to accumulate in ubiquitinated inclusions of amyotrophic lateral sclerosis affected motor neurons, resulting in motor neuron degeneration, loss of motor functions, and eventually death....
8.
Bialucha C, Collins S, Li X, Saxena P, Zhang X, Durr C, et al.
Cancer Discov
. 2017 May;
7(9):1030-1045.
PMID: 28526733
Despite an improving therapeutic landscape, significant challenges remain in treating the majority of patients with advanced ovarian or renal cancer. We identified the cell-cell adhesion molecule cadherin-6 () as a...
9.
Demers C, Cox G, Collins S, Smith R
Annu Int Conf IEEE Eng Med Biol Soc
. 2017 Mar;
2016:477-480.
PMID: 28268375
Embryonic development of the spinal cord proceeds through a carefully orchestrated temporal and spatial sequence of chemical cues to provide precise patterning of adult cell types. Recreating this complex microenvironment...
10.
Demers C, Soundararajan P, Chennampally P, Cox G, Briscoe J, Collins S, et al.
Development
. 2016 Jun;
143(11):1884-92.
PMID: 27246712
Embryogenesis is a highly regulated process in which the precise spatial and temporal release of soluble cues directs differentiation of multipotent stem cells into discrete populations of specialized adult cell...